CGEM Institutional Ownership
Cullinan Therapeutics, Inc.
Latest close $17.73 as of Aug 7, 2026
CGEM institutional ownership at a glance
Follow Cullinan Therapeutics, Inc. institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: Citadel Advisors filed Schedule 13G amendment on Nov 14, 2025, reporting 2.0M shares and 3.40% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 accumulating, 1 exited across 2 comparable institutions.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 4 filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Citadel Advisors CIK0001423053 | Sep 30, 2025 observed Nov 14, 2025 filed · 45d Schedule 13G amendment | Exit below reporting threshold | 2.0M -1.0M | 3.40% -1.70 pts | $5.93 | $8.55 | $17.73 |
| Citadel Advisors CIK0001423053 | Jul 30, 2025 observed Aug 6, 2025 filed · 7d Initial Schedule 13G | Initial Schedule 13G | 3.0M | 5.10% | $8.16 | $7.88 | $17.73 |
| BlackRock CIK0001364742 | May 31, 2024 observed Jun 7, 2024 filed · 7d Schedule 13G amendment | Reported accumulation | 2.7M +712.1K | 4.80% 0.00 pts | $23.50 | $22.40 | $17.73 |
Related research
Compare CGEM with other securities showing similar institutional activity or recent accumulation across several tracked institutions.